A Systems Approach Identifies Networks and Genes Linking Sleep and Stress: Implications for Neuropsychiatric Disorders

Cell Reports

Volumn 11, Issue 5, 2015, Pages 835-848

  Jiang, Peng ^a   Scarpa, Joseph R ^b   Fitzpatrick, Karrie ^a   Losic, Bojan ^b   Gao, Vance D ^a   Hao, Ke ^b   Summa, Keith C ^a   Yang, He S ^a   Zhang, Bin ^b   Allada, Ravi ^a   Vitaterna, Martha H ^a   Turek, Fred W ^a   Kasarskis, Andrew ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; GENE EXPRESSION; GENE REGULATORY NETWORK; GENETIC REGULATION; MENTAL DISEASE; MITOCHONDRION; MOUSE; NERVE CELL NETWORK; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SLEEP; STATISTICAL ANALYSIS; STRESS; SYNAPSE; ANIMAL; BAYES THEOREM; C57BL MOUSE; GENETICS; MENTAL STRESS; METABOLISM; PATHOLOGY; PHENOTYPE; QUANTITATIVE TRAIT LOCUS; VETERINARY;

MUS;

ACTIN BINDING PROTEIN; TRANSCRIPTOME;

ANIMALS; BAYES THEOREM; GENE REGULATORY NETWORKS; MENTAL DISORDERS; MICE, INBRED C57BL; MICROFILAMENT PROTEINS; PHENOTYPE; QUANTITATIVE TRAIT LOCI; SLEEP; STRESS, PSYCHOLOGICAL; TRANSCRIPTOME;

EID: 84933677987     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.04.003     Document Type: Article

References (84)

1. Ahmad A., Rasheed N., Banu N., Palit G. Alterations in monoamine levels and oxidative systems in frontal cortex, striatum, and hippocampus of the rat brain during chronic unpredictable stress. Stress 2010, 13:355-364.
2. Altrock W.D., tom Dieck S., Sokolov M., Meyer A.C., Sigler A., Brakebusch C., Fässler R., Richter K., Boeckers T.M., Potschka H., et al. Functional inactivation of a fraction of excitatory synapses in mice deficient for the active zone protein bassoon. Neuron 2003, 37:787-800.
3. Archer S.N., Laing E.E., Möller-Levet C.S., van der Veen D.R., Bucca G., Lazar A.S., Santhi N., Slak A., Kabiljo R., von Schantz M., et al. Mistimed sleep disrupts circadian regulation of the human transcriptome. Proc. Natl. Acad. Sci. USA 2014, 111:E682-E691.
4. Armario A., Martí O., Gavaldà A., Giralt M., Jolín T. Effects of chronic immobilization stress on GH and TSH secretion in the rat: response to hypothalamic regulatory factors. Psychoneuroendocrinology 1993, 18:405-413.
5. Blake J.A., Bult C.J., Eppig J.T., Kadin J.A., Richardson J.E., Group M.G.D. The Mouse Genome Database: integration of and access to knowledge about the laboratory mouse. Nucleic Acids Res. 2014, 42:D810-D817. Mouse Genome Database Group.
6. Braunstein K.E., Eschbach J., Ròna-Vörös K., Soylu R., Mikrouli E., Larmet Y., René F., Gonzalez De Aguilar J.L., Loeffler J.P., Müller H.P., et al. A point mutation in the dynein heavy chain gene leads to striatal atrophy and compromises neurite outgrowth of striatal neurons. Hum. Mol. Genet. 2010, 19:4385-4398.
7. Breslau N., Roth T., Rosenthal L., Andreski P. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol. Psychiatry 1996, 39:411-418.
8. Brunner J.I., Gotter A.L., Millstein J., Garson S., Binns J., Fox S.V., Savitz A.T., Yang H.S., Fitzpatrick K., Zhou L., et al. Pharmacological validation of candidate causal sleep genes identified in an N2 cross. J.Neurogenet. 2011, 25:167-181.
9. Chang P.P., Ford D.E., Mead L.A., Cooper-Patrick L., Klag M.J. Insomnia in young men and subsequent depression. The Johns Hopkins Precursors Study. Am. J. Epidemiol. 1997, 146:105-114.
10. Chen Z.-Y., Jing D., Bath K.G., Ieraci A., Khan T., Siao C.-J., Herrera D.G., Toth M., Yang C., McEwen B.S., et al. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 2006, 314:140-143.
11. Chen Y., Zhu J., Lum P.Y., Yang X., Pinto S., MacNeil D.J., Zhang C., Lamb J., Edwards S., Sieberts S.K., et al. Variations in DNA elucidate molecular networks that cause disease. Nature 2008, 452:429-435.
12. Cohen H., Ziv Y., Cardon M., Kaplan Z., Matar M.A., Gidron Y., Schwartz M., Kipnis J. Maladaptation to mental stress mitigated by the adaptive immune system via depletion of naturally occurring regulatory CD4+CD25+ cells. J.Neurobiol. 2006, 66:552-563.
13. Courchet J., Lewis T.L., Lee S., Courchet V., Liou D.-Y., Aizawa S., Polleux F. Terminal axon branching is regulated by the LKB1-NUAK1 kinase pathway via presynaptic mitochondrial capture. Cell 2013, 153:1510-1525.
14. Crews D., Gillette R., Scarpino S.V., Manikkam M., Savenkova M.I., Skinner M.K. Epigenetic transgenerational inheritance of altered stress responses. Proc. Natl. Acad. Sci. USA 2012, 109:9143-9148.
15. Dick D.M., Aliev F., Krueger R.F., Edwards A., Agrawal A., Lynskey M., Lin P., Schuckit M., Hesselbrock V., Nurnberger J., et al. Genome-wide association study of conduct disorder symptomatology. Mol. Psychiatry 2011, 16:800-808.
16. Earley C.J., Kuwabara H., Wong D.F., Gamaldo C., Salas R.E., Brašić J.R., Ravert H.T., Dannals R.F., Allen R.P. Increased synaptic dopamine in the putamen in restless legs syndrome. Sleep 2013, 36:51-57.
17. Emilsson V., Thorleifsson G., Zhang B., Leonardson A.S., Zink F., Zhu J., Carlson S., Helgason A., Walters G.B., Gunnarsdottir S., et al. Genetics of gene expression and its effect on disease. Nature 2008, 452:423-428.
18. Eschbach J., Fergani A., Oudart H., Robin J.P., Rene F., Gonzalez de Aguilar J.L., Larmet Y., Zoll J., Hafezparast M., Schwalenstocker B., et al. Mutations in cytoplasmic dynein lead to a Huntington's disease-like defect in energy metabolism of brown and white adipose tissues. Biochim. Biophys. Acta 2011, 1812:59-69.
19. Fan X., Molotkov A., Manabe S., Donmoyer C.M., Deltour L., Foglio M.H., Cuenca A.E., Blaner W.S., Lipton S.A., Duester G. Targeted disruption of Aldh1a1 (Raldh1) provides evidence for a complex mechanism of retinoic acid synthesis in the developing retina. Mol. Cell. Biol. 2003, 23:4637-4648.
20. Feder A., Nestler E.J., Charney D.S. Psychobiology and molecular genetics of resilience. Nat. Rev. Neurosci. 2009, 10:446-457.
21. Galici R., Jones C.K., Hemstapat K., Nong Y., Echemendia N.G., Williams L.C., de Paulis T., Conn P.J. Biphenyl-indanone A, a positive allosteric modulator of the metabotropic glutamate receptor subtype 2, has antipsychotic- and anxiolytic-like effects in mice. J.Pharmacol. Exp. Ther. 2006, 318:173-185.
22. Gershenfeld H.K., Paul S.M. Mapping quantitative trait loci for fear-like behaviors in mice. Genomics 1997, 46:1-8.
23. Goldstein A.N., Walker M.P. The role of sleep in emotional brain function. Annu. Rev. Clin. Psychol. 2014, 10:679-708.
24. Hamilton S.P., Fyer A.J., Durner M., Heiman G.A., Baisre de Leon A., Hodge S.E., Knowles J.A., Weissman M.M. Further genetic evidence for a panic disorder syndrome mapping to chromosome 13q. Proc. Natl. Acad. Sci. USA 2003, 100:2550-2555.
25. Kibel A., Drenjancević-Perić I. Impact of glucocorticoids and chronic stress on progression of Parkinson's disease. Med. Hypotheses 2008, 71:952-956.
26. Kim Y.K., Yoon I.-Y., Kim J.-M., Jeong S.-H., Kim K.W., Shin Y.-K., Kim B.S., Kim S.E. The implication of nigrostriatal dopaminergic degeneration in the pathogenesis of REM sleep behavior disorder. Eur. J. Neurol. 2010, 17:487-492.
27. Kipnis J., Gadani S., Derecki N.C. Pro-cognitive properties of Tcells. Nat. Rev. Immunol. 2012, 12:663-669.
28. Kitaoka K., Shimizu M., Shimizu N., Chikahisa S., Nakagomi M., Shudo K., Yoshizaki K., Séi H. Retinoic acid receptor antagonist LE540 attenuates wakefulness via the dopamine D1 receptor in mice. Brain Res. 2011, 1423:10-16.
29. Kroes R.A., Panksepp J., Burgdorf J., Otto N.J., Moskal J.R. Modeling depression: social dominance-submission gene expression patterns in rat neocortex. Neuroscience 2006, 137:37-49.
30. Lamprecht R., Farb C.R., LeDoux J.E. Fear memory formation involves p190 RhoGAP and ROCK proteins through a GRB2-mediated complex. Neuron 2002, 36:727-738.
31. Lazarus M., Huang Z.L., Lu J., Urade Y., Chen J.F. How do the basal ganglia regulate sleep-wake behavior?. Trends Neurosci. 2012, 35:723-732.
32. Lein E.S., Hawrylycz M.J., Ao N., Ayres M., Bensinger A., Bernard A., Boe A.F., Boguski M.S., Brockway K.S., Byrnes E.J., et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 2007, 445:168-176.
33. Li R., Lyons M.A., Wittenburg H., Paigen B., Churchill G.A. Combining data from multiple inbred line crosses improves the power and resolution of quantitative trait loci mapping. Genetics 2005, 169:1699-1709.
34. Li Y., Grupe A., Rowland C., Holmans P., Segurado R., Abraham R., Jones L., Catanese J., Ross D., Mayo K., et al. Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's disease. Hum. Mol. Genet. 2008, 17:759-767.
35. Liang C., Feng P., Ku B., Dotan I., Canaani D., Oh B.-H., Jung J.U. Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat. Cell Biol. 2006, 8:688-699.
36. Lim D.A., Huang Y.-C., Swigut T., Mirick A.L., Garcia-Verdugo J.M., Wysocka J., Ernst P., Alvarez-Buylla A. Chromatin remodelling factor Mll1 is essential for neurogenesis from postnatal neural stem cells. Nature 2009, 458:529-533.
37. Lupien S.J., McEwen B.S., Gunnar M.R., Heim C. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat. Rev. Neurosci. 2009, 10:434-445.
38. Lüscher C., Slesinger P.A. Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease. Nat. Rev. Neurosci. 2010, 11:301-315.
39. Manji H., Kato T., Di Prospero N.A., Ness S., Beal M.F., Krams M., Chen G. Impaired mitochondrial function in psychiatric disorders. Nat. Rev. Neurosci. 2012, 13:293-307.
40. Martinez-Gonzalez D., Obermeyer W., Fahy J.L., Riboh M., Kalin N.H., Benca R.M. REM sleep deprivation induces changes in coping responses that are not reversed by amphetamine. Sleep 2004, 27:609-617.
41. McLachlan S.M., Hamidi S., Aliesky H., Williams R.W., Rapoport B. Sex, genetics and the control of thyroxine and thyrotropin in mice. Thyroid 2014, 24:1080-1087.
42. Menz M.M., Rihm J.S., Salari N., Born J., Kalisch R., Pape H.C., Marshall L., Büchel C. The role of sleep and sleep deprivation in consolidating fear memories. Neuroimage 2013, 75:87-96.
43. Millstein J., Zhang B., Zhu J., Schadt E.E. Disentangling molecular relationships with a causal inference test. BMC Genet. 2009, 10:23.
44. Millstein J., Winrow C.J., Kasarskis A., Owens J.R., Zhou L., Summa K.C., Fitzpatrick K., Zhang B., Vitaterna M.H., Schadt E.E., et al. Identification of causal genes, networks, and transcriptional regulators of REM sleep and wake. Sleep 2011, 34:1469-1477.
45. Minkel J.D., Banks S., Htaik O., Moreta M.C., Jones C.W., McGlinchey E.L., Simpson N.S., Dinges D.F. Sleep deprivation and stressors: evidence for elevated negative affect in response to mild stressors when sleep deprived. Emotion 2012, 12:1015-1020.
46. Morgan A.D., Carroll M.E., Loth A.K., Stoffel M., Wickman K. Decreased cocaine self-administration in Kir3 potassium channel subunit knockout mice. Neuropsychopharmacology 2003, 28:932-938.
47. Morton A.J. Circadian and sleep disorder in Huntington's disease. Exp. Neurol. 2013, 243:34-44.
48. Moy S.S., Nadler J.J., Young N.B., Nonneman R.J., Grossman A.W., Murphy D.L., D'Ercole A.J., Crawley J.N., Magnuson T.R., Lauder J.M. Social approach in genetically engineered mouse lines relevant to autism. Genes Brain Behav. 2009, 8:129-142.
49. Mychasiuk R., Gibb R., Kolb B. Prenatal stress produces sexually dimorphic and regionally specific changes in gene expression in hippocampus and frontal cortex of developing rat offspring. Dev. Neurosci. 2011, 33:531-538.
50. O'Hara B.F., Ding J., Bernat R.L., Franken P. Genomic and proteomic approaches towards an understanding of sleep. CNS Neurol. Disord. Drug Targets 2007, 6:71-81.
51. Oldham M.C., Konopka G., Iwamoto K., Langfelder P., Kato T., Horvath S., Geschwind D.H. Functional organization of the transcriptome in human brain. Nat. Neurosci. 2008, 11:1271-1282.
52. Parikshak N.N., Luo R., Zhang A., Won H., Lowe J.K., Chandran V., Horvath S., Geschwind D.H. Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism. Cell 2013, 155:1008-1021.
53. Polta S.A., Fenzl T., Jakubcakova V., Kimura M., Yassouridis A., Wotjak C.T. Prognostic and symptomatic aspects of rapid eye movement sleep in a mouse model of posttraumatic stress disorder. Front. Behav. Neurosci. 2013, 7:60.
54. Ponder C.A., Huded C.P., Munoz M.B., Gulden F.O., Gilliam T.C., Palmer A.A. Rapid selection response for contextual fear conditioning in a cross between C57BL/6J and A/J: behavioral, QTL and gene expression analysis. Behav. Genet. 2008, 38:277-291.
55. Postuma R.B., Aarsland D., Barone P., Burn D.J., Hawkes C.H., Oertel W., Ziemssen T. Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease. Mov. Disord. 2012, 27:617-626.
56. Pravetoni M., Wickman K. Behavioral characterization of mice lacking GIRK/Kir3 channel subunits. Genes Brain Behav. 2008, 7:523-531.
57. Qiu M.H., Vetrivelan R., Fuller P.M., Lu J. Basal ganglia control of sleep-wake behavior and cortical activation. Eur. J. Neurosci. 2010, 31:499-507.
58. Rossi S., De Chiara V., Musella A., Mataluni G., Sacchetti L., Bernardi G., Usiello A., Centonze D. Adaptations of striatal endocannabinoid system during stress. Mol. Neurobiol. 2009, 39:178-184.
59. Sauerbier A., Ray Chaudhuri K. Non-motor symptoms: the core of multi-morbid Parkinson's disease. Br. J. Hosp. Med. (Lond.) 2014, 75:18-24.
60. Schadt E.E., Lamb J., Yang X., Zhu J., Edwards S., Guhathakurta D., Sieberts S.K., Monks S., Reitman M., Zhang C., et al. An integrative genomics approach to infer causal associations between gene expression and disease. Nat. Genet. 2005, 37:710-717.
61. Schwartz M., Kipnis J. A conceptual revolution in the relationships between the brain and immunity. Brain Behav. Immun. 2011, 25:817-819.
62. Shepherd G.M. Corticostriatal connectivity and its role in disease. Nat. Rev. Neurosci. 2013, 14:278-291.
63. Shirbin C.A., Chua P., Churchyard A., Lowndes G., Hannan A.J., Pang T.Y., Chiu E., Stout J.C. Cortisol and depression in pre-diagnosed and early stage Huntington's disease. Psychoneuroendocrinology 2013, 38:2439-2447.
64. Smith S.M., Uslaner J.M., Cox C.D., Huszar S.L., Cannon C.E., Vardigan J.D., Eddins D., Toolan D.M., Kandebo M., Yao L., et al. The novel phosphodiesterase 10A inhibitor THPP-1 has antipsychotic-like effects in rat and improves cognition in rat and rhesus monkey. Neuropharmacology 2013, 64:215-223.
65. Stengel A., Rivier J., Taché Y. Modulation of the adaptive response to stress by brain activation of selective somatostatin receptor subtypes. Peptides 2013, 42:70-77.
66. Stoffers D., Altena E., van der Werf Y.D., Sanz-Arigita E.J., Voorn T.A., Astill R.G., Strijers R.L.M., Waterman D., Van Someren E.J.W. The caudate: a key node in the neuronal network imbalance of insomnia?. Brain 2013.
67. Suchecki D., Tiba P.A., Machado R.B. REM Sleep Rebound as an Adaptive Response to Stressful Situations. Front Neurol 2012, 3:41.
68. Sun T., Qiao H., Pan P.-Y., Chen Y., Sheng Z.-H. Motile axonal mitochondria contribute to the variability of presynaptic strength. Cell Rep. 2013, 4:413-419.
69. Tissir F., Bar I., Jossin Y., De Backer O., Goffinet A.M. Protocadherin Celsr3 is crucial in axonal tract development. Nat. Neurosci. 2005, 8:451-457.
70. Tochigi M., Iwamoto K., Bundo M., Sasaki T., Kato N., Kato T. Gene expression profiling of major depression and suicide in the prefrontal cortex of postmortem brains. Neurosci. Res. 2008, 60:184-191.
71. Tordera R.M., Totterdell S., Wojcik S.M., Brose N., Elizalde N., Lasheras B., Del Rio J. Enhanced anxiety, depressive-like behaviour and impaired recognition memory in mice with reduced expression of the vesicular glutamate transporter 1 (VGLUT1). Eur. J. Neurosci. 2007, 25:281-290.
72. Tritsch N.X., Sabatini B.L. Dopaminergic modulation of synaptic transmission in cortex and striatum. Neuron 2012, 76:33-50.
73. Turek F.W. From circadian rhythms to clock genes in depression. Int. Clin. Psychopharmacol. 2007, 22(Suppl 2):S1-S8.
74. van den Heuvel O.A., van der Werf Y.D., Verhoef K.M., de Wit S., Berendse H.W., Wolters E.Ch., Veltman D.J., Groenewegen H.J. Frontal-striatal abnormalities underlying behaviours in the compulsive-impulsive spectrum. J.Neurol. Sci. 2010, 289:55-59.
75. Varty G.B., Grilli M., Forlani A., Fredduzzi S., Grzelak M.E., Guthrie D.H., Hodgson R.A., Lu S.X., Nicolussi E., Pond A.J., et al. The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles. Psychopharmacology (Berl.) 2005, 179:207-217.
76. Wang I.M., Zhang B., Yang X., Zhu J., Stepaniants S., Zhang C., Meng Q., Peters M., He Y., Ni C., et al. Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers. Mol. Syst. Biol. 2012, 8:594.
77. Welter D., MacArthur J., Morales J., Burdett T., Hall P., Junkins H., Klemm A., Flicek P., Manolio T., Hindorff L., Parkinson H. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res. 2014, 42:D1001-D1006.
78. Yu H., Wang D.-D., Wang Y., Liu T., Lee F.S., Chen Z.-Y. Variant brain-derived neurotrophic factor Val66Met polymorphism alters vulnerability to stress and response to antidepressants. J.Neurosci. 2012, 32:4092-4101.
79. Zhang S., Gershenfeld H.K. Genetic contributions to body weight in mice: relationship of exploratory behavior to weight. Obes. Res. 2003, 11:828-838.
80. Zhang B., Horvath S. A general framework for weighted gene co-expression network analysis. Stat. Appl. Genet. Mol. Biol. 2005, 4. Article17.
81. Zhang B., Gaiteri C., Bodea L.-G., Wang Z., McElwee J., Podtelezhnikov A.A., Zhang C., Xie T., Tran L., Dobrin R., et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer s Disease. Cell 2013, 153:707-720.
82. Zhao Z., Oh S., Li D., Ni D., Pirooz S.D., Lee J.H., Yang S., Lee J.Y., Ghozalli I., Costanzo V., et al. A dual role for UVRAG in maintaining chromosomal stability independent of autophagy. Dev. Cell 2012, 22:1001-1016.
83. Zhou Y., Gunput R.-A.F., Adolfs Y., Pasterkamp R.J. MICALs in control of the cytoskeleton, exocytosis, and cell death. Cell. Mol. Life Sci. 2011, 68:4033-4044.
84. Zhu J., Sova P., Xu Q., Dombek K.M., Xu E.Y., Vu H., Tu Z., Brem R.B., Bumgarner R.E., Schadt E.E. Stitching together multiple data dimensions reveals interacting metabolomic and transcriptomic networks that modulate cell regulation. PLoS Biol. 2012, 10:e1001301.